Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 4
1982 4
1983 6
1984 5
1985 10
1986 7
1987 18
1988 15
1989 16
1990 24
1991 21
1992 31
1993 29
1994 18
1995 46
1996 54
1997 62
1998 56
1999 48
2000 55
2001 57
2002 81
2003 96
2004 97
2005 129
2006 131
2007 175
2008 218
2009 238
2010 298
2011 292
2012 325
2013 422
2014 476
2015 517
2016 553
2017 552
2018 730
2019 843
2020 1034
2021 1193
2022 1432
2023 1545
2024 751

Text availability

Article attribute

Article type

Publication date

Search Results

11,484 results

Results by year

Filters applied: . Clear all
Page 1
Augmentation of scleral glycolysis promotes myopia through histone lactylation.
Lin X, Lei Y, Pan M, Hu C, Xie B, Wu W, Su J, Li Y, Tan Y, Wei X, Xue Z, Xu R, Di M, Deng H, Liu S, Yang X, Qu J, Chen W, Zhou X, Zhao F. Lin X, et al. Among authors: xu r. Cell Metab. 2024 Mar 5;36(3):511-525.e7. doi: 10.1016/j.cmet.2023.12.023. Epub 2024 Jan 16. Cell Metab. 2024. PMID: 38232735
R-Mixup: Riemannian Mixup for Biological Networks.
Kan X, Li Z, Cui H, Yu Y, Xu R, Yu S, Zhang Z, Guo Y, Yang C. Kan X, et al. Among authors: xu r. KDD. 2023 Aug;2023:1073-1085. doi: 10.1145/3580305.3599483. Epub 2023 Aug 4. KDD. 2023. PMID: 38343707 Free PMC article.
The role of proteasomes in tumorigenesis.
Zhou X, Xu R, Wu Y, Zhou L, Xiang T. Zhou X, et al. Among authors: xu r. Genes Dis. 2023 Aug 6;11(4):101070. doi: 10.1016/j.gendis.2023.06.037. eCollection 2024 Jul. Genes Dis. 2023. PMID: 38523673 Free PMC article. Review.
Gross Chromosomal Rearrangement at Centromeres.
Xu R, Pan Z, Nakagawa T. Xu R, et al. Biomolecules. 2023 Dec 24;14(1):28. doi: 10.3390/biom14010028. Biomolecules. 2023. PMID: 38254628 Free PMC article. Review.
Charting the cellular biogeography in colitis reveals fibroblast trajectories and coordinated spatial remodeling.
Cadinu P, Sivanathan KN, Misra A, Xu RJ, Mangani D, Yang E, Rone JM, Tooley K, Kye YC, Bod L, Geistlinger L, Lee T, Mertens RT, Ono N, Wang G, Sanmarco L, Quintana FJ, Anderson AC, Kuchroo VK, Moffitt JR, Nowarski R. Cadinu P, et al. Among authors: xu rj. Cell. 2024 Apr 11;187(8):2010-2028.e30. doi: 10.1016/j.cell.2024.03.013. Epub 2024 Apr 2. Cell. 2024. PMID: 38569542
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Among authors: xu r. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
Tumor iron homeostasis and immune regulation.
Zhang YY, Han Y, Li WN, Xu RH, Ju HQ. Zhang YY, et al. Among authors: xu rh. Trends Pharmacol Sci. 2024 Feb;45(2):145-156. doi: 10.1016/j.tips.2023.12.003. Epub 2024 Jan 11. Trends Pharmacol Sci. 2024. PMID: 38212195 Review.
Solitary circumscribed alopecia.
Zhang LW, Wu J, Xu RH, Chen T. Zhang LW, et al. Among authors: xu rh. BMJ. 2024 Feb 22;384:e076986. doi: 10.1136/bmj-2023-076986. BMJ. 2024. PMID: 38387993 No abstract available.
The palmitoylation of gasdermin D directs its membrane translocation and pore formation during pyroptosis.
Balasubramanian A, Hsu AY, Ghimire L, Tahir M, Devant P, Fontana P, Du G, Liu X, Fabin D, Kambara H, Xie X, Liu F, Hasegawa T, Xu R, Yu H, Chen M, Kolakowski S, Trauger S, Larsen MR, Wei W, Wu H, Kagan JC, Lieberman J, Luo HR. Balasubramanian A, et al. Among authors: xu r. Sci Immunol. 2024 Apr 12;9(94):eadn1452. doi: 10.1126/sciimmunol.adn1452. Epub 2024 Apr 12. Sci Immunol. 2024. PMID: 38530158
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial.
Wang F, Jin Y, Wang M, Luo HY, Fang WJ, Wang YN, Chen YX, Huang RJ, Guan WL, Li JB, Li YH, Wang FH, Hu XH, Zhang YQ, Qiu MZ, Liu LL, Wang ZX, Ren C, Wang DS, Zhang DS, Wang ZQ, Liao WT, Tian L, Zhao Q, Xu RH. Wang F, et al. Among authors: xu rh. Nat Med. 2024 Apr;30(4):1035-1043. doi: 10.1038/s41591-024-02813-1. Epub 2024 Mar 4. Nat Med. 2024. PMID: 38438735 Clinical Trial.
11,484 results
You have reached the last available page of results. Please see the User Guide for more information.